Uncover the critical evidence of success
You’ve spent the millions of dollars to shepherd your product through development and you’ve gained market approval, but there’s more work to be done to increase the likelihood of long-term success. Stakeholders are demanding evidence to support regulatory, reimbursement and prescribing decisions. Staying ahead of competitors will require that you find a way to efficiently conduct real-world and late phase research that leads to the right information for the right stakeholders at the right time.
The advantage of agile and efficient post-marketing study design and execution
A leader in interventional Phase IIIb/IV studies, Quintiles is a fully integrated biopharmaceutical services provider offering clinical, commercial and consulting solutions. We’ll help you find the right approach to get the right answers for the stakeholders who have a vested interest in your product. Our post-marketing capabilities include:
In the past 3 years, we’ve conducted more than 225 Phase IIIb and Phase IV trials to:
- Global infrastructure and site relationships to scale up to deliver large sutides quickly and efficiently.
- Integrated expertise in health outcomes, biostatistics, epidemiology and post-marketing regulations.
- Streamlined operations that reduce time and cost.
- Support new indications or label extensions.
- Obtain or expand market access.
- Support product differentiation and positioning.
- Demonstrate efficacy and comparative effectiveness.
- Meet post-marketing commitments.
- Evaluate and monitor safety.
Success for your product doesn’t stop at market approval. With an excellent record of post-marketing research success, Quintiles stands ready to help your product reach its optimal potential.